This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks Hitting 52-Week Highs Today


Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Akorn (AKRX - Get Report) manufactures and markets a range of diagnostic and therapeutic ophthalmic pharmaceuticals, as well as niche hospital drugs and injectable pharmaceuticals. This stock is trading up 11% to $9.98 in recent trading, after it hit a 52-week high of $10.10 earlier today.

Today's Range: $8.85-$10.10

52-Week Range: $4.37-$10.10

Volume: 3.1 million

Three-Month Average Volume: 1.12 million

Akron has a market cap of $946.41 million and an enterprise value of $815.25 million. The stock trades at a trailing price-to-earnings of 20.56 and a forward price-to-earnings of 29.38. Its estimated growth rate for this year is 61.10%, and for next year it's pegged at 17.20%. The current short interest as a percentage of the float for Akron is notable at 7.7%.

This company reported record third-quarter earnings today on revenue of $36.6 million, a 69% increase from the same quarter last year. The company also raised its 2011 outlook to $130 million to $132 million.

From a technical standpoint, this stock has triggered a major breakout today on high volume now that the stock has punched through some past overhead resistance at $9.50 a share. This move today is pushing AKRX to brand new all-time highs. As long as the stock can sustain a move and close above $9.50, then it should be setting up to trend significantly higher.

I recently included Akron in a list of stocks under $10 setting up to trade higher.
2 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
YHOO $27.05 -3.29%
AKRX $24.06 -4.64%
AMT $85.41 -3.86%
MGAM $36.44 -0.03%
LGF $19.17 3.45%


Chart of I:DJI
DOW 16,027.05 -177.92 -1.10%
S&P 500 1,853.44 -26.61 -1.42%
NASDAQ 4,283.7530 -79.3910 -1.82%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs